[Desmopressin: the treatment of primary nocturnal enuresis].
The efficacy of desmopressin, a drug that reduces nocturnal urine volume with no side effects, was evaluated in a group of 21 patients. 20 boys and 1 girl with primary nocturnal enuresis were treated with intranasal desmopressin (DDAVP) for a period of 12 weeks. An improvement in 80.95% was achieved. Following treatment enuresis recurred, but to a lesser degree than before therapy. DDAVP is useful in the treatment of primary nocturnal enuresis whose etiology is not organic or functional.